What Is the Life Expectancy for Mesothelioma?
The average life expectancy for mesothelioma is 12 to 21 months after diagnosis. However, many factors influence individual outcomes, and some patients live significantly longer with appropriate treatment.
Average Life Expectancy by Type
Life expectancy for mesothelioma varies based on the type of disease. Pleural mesothelioma, which develops in the lining of the lungs, has a median life expectancy of approximately 12 to 18 months. Peritoneal mesothelioma, affecting the abdominal lining, has shown significantly better outcomes — patients treated with cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) have achieved median survival times exceeding 53 months.
Pericardial and testicular mesothelioma are extremely rare, and survival data is limited. Pericardial mesothelioma generally carries a poor prognosis, while testicular mesothelioma tends to have a somewhat more favorable outlook.
Factors That Influence Life Expectancy
Several factors play a role in determining an individual patient's life expectancy. Stage at diagnosis is among the most important — patients diagnosed at stage I or II generally live longer than those diagnosed at stage III or IV. Cell type also matters significantly, with epithelioid mesothelioma carrying the best prognosis.
Younger patients and those in good overall health tend to tolerate aggressive treatment better, which can extend survival. Access to experienced mesothelioma treatment centers and eligibility for clinical trials may also improve outcomes. A patient's response to initial treatment is often a strong predictor of long-term survival.
Extending Life Expectancy
While mesothelioma remains a serious diagnosis, treatment advances continue to improve survival statistics. Immunotherapy drugs such as nivolumab and ipilimumab have become standard treatment options and have extended life for some patients. Multimodal approaches combining surgery, chemotherapy, and radiation offer the best chance for longer survival in eligible patients.
Pursuing financial compensation through legal claims can help ensure access to top treatment centers and specialists. Families dealing with a mesothelioma diagnosis should also explore resources available through patient and family support programs to make informed decisions about care.
- Average Life Expectancy: 12–21 months from diagnosis
- Stage I Patients: May survive 21 months or longer with treatment
- Peritoneal Mesothelioma: Median survival of 53+ months with HIPEC surgery
- Long-Term Survivors: Some patients live 5 years or more, particularly with early-stage epithelioid disease
Reviewed by: Rod De Llano, J.D. — Texas Bar — 30+ years mesothelioma litigation
Last updated: March 15, 2026
Sources: American Cancer Society — Survival Rates for Mesothelioma, National Cancer Institute — Malignant Mesothelioma Treatment, Annals of Translational Medicine — Long-Term Survivors of Malignant Mesothelioma
Our attorneys have handled mesothelioma cases for over 30 years. We can evaluate your situation, explain every option available to you, and answer your questions — all at no cost and with no obligation.
Request a Free Consultation
Your information is confidential and protected. We typically respond within 24 hours.
Call 1-800-400-1805 for immediate help.